TerrAscend Corp. (TSNDF) stock
Close on Oct 19, 2026Market cap $142.31MP/E –Yield –
TerrAscend Corp. grew revenue 2.4% to $267.02M over the twelve months to Sep 30, 2026. Operating income fell 9.7% to $41.58M, moving the operating margin from 17.6% to 15.6%. Free cash flow was $25.00M, up 83.7% from a year earlier. At the latest close the market valued the company at $142.31M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $142.31M
- P/E ratio
- –
- Price to sales
- 0.53
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 17.57%
Fundamentals
- Revenue
- $267.02M
- Net income
- -$17.93M
- EPS, diluted
- -$0.07
- Free cash flow
- $25.00M
- Diluted shares
- 309M
Trading
- Next earnings
- Mar 11, 2027 (estimated, during market hours)
- Previous close
- $0.47
- Open
- $0.49
- Day's range
- $0.46 – $0.50
- Volume
- 304,516
- Average volume (20 days)
- 363,774
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | TSNDF | S&P 500 | Difference | TSNDF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -29.6% | +0.6% | −30.2 pts | ||
| 3 months | -19.6% | +3.4% | −23.0 pts | ||
| Year to date | -36.0% | +13.3% | −49.3 pts | ||
| 1 year | -38.6% | +16.6% | −55.2 pts | ||
| 3 years | -75.5% | +86.4% | −161.9 pts | -37.4% | +23.1% |
| 5 years | -92.4% | +81.9% | −174.3 pts | -40.4% | +12.7% |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases TerrAscend filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- News
- News
- News
About TerrAscend
Agricultural Production-Crops
TerrAscend Corp. is a cannabis company that cultivates, processes, and sells medical and adult-use cannabis products. The enterprise functions under a single reportable business segment covering cannabis cultivation, manufacturing, and retail sales. Its product lines encompass dried flower, concentrates, vaporizables, edibles, topicals, and tinctures, marketed through proprietary brands alongside licensed third-party labels. The company serves medical patients as well as recreational adult-use consumers.
Company profile, executives and historyTerrAscend stock: common questions
What is TerrAscend's stock price?
TSNDF closed at $0.46 on Oct 19, 2026, down 2.54% on the day.
What is TerrAscend's market cap?
TerrAscend was worth $142.31M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is TSNDF's P/E ratio?
TerrAscend lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.07), so it has no meaningful P/E ratio.
How much revenue does TerrAscend make?
TerrAscend reported revenue of $267.02M for the twelve months to Sep 30, 2026, up 2.4% from a year earlier.
Does TerrAscend pay a dividend?
No. TerrAscend has not paid a cash dividend over the last twelve months.
When does TerrAscend report earnings next?
TerrAscend is expected to report Q4 FY2026 results on Mar 11, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has TSNDF stock performed over the past year?
Including dividends, TSNDF returned -38.6% over the past year, against +16.6% for the S&P 500.
Who are TerrAscend's competitors?
Companies most similar to TerrAscend by business, industry and size include ITHUF, VFF, VRNO, PLNH, GTBIF.
See a number that looks wrong?